Kaposi sarcoma-associated herpes virus targets the lymphotactin receptor with both a broad spectrum antagonist vCCL2 and a highly selective and potent agonist vCCL3
about
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and InflammationSystematic classification of vertebrate chemokines based on conserved synteny and evolutionary historyHuman herpesvirus 8-encoded cytokines.Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Gating function of isoleucine-116 in TM-3 (position III:16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5).New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist.Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines.Chemokines encoded by herpesviruses.Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells.Cytomegalovirus expresses the chemokine homologue vXCL1 capable of attracting XCR1+ CD4- dendritic cells.The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor.CXCR7 Targeting and Its Major Disease Relevance.
P2860
Q26796395-E881B41F-3474-4528-934A-5364A609C900Q27025252-FB903EC0-5AD9-4FA3-9FE1-CAE4FDB80283Q33813244-B175B637-51DF-43E6-B60D-B4514D917FD7Q34013830-AEBF249B-2CEA-4AF8-9BE4-8E026D9C5159Q34609062-0308A7DE-AA57-45B5-B400-ABFEC49B9C3BQ37432097-B2CC8F86-8351-499F-9D56-B3E16F9658AFQ38274861-62C3EE9A-0493-4497-937D-6A204E60B173Q38815332-72C67EA6-7E3B-44A1-ABB3-C87F1E512033Q39616316-78C44E35-BED5-45D0-B4D9-A7120A3D972FQ39767301-B0DADE0D-CF69-47C8-948A-E713B0941F79Q40067378-B6B8B136-5F57-4AC2-AC29-AE073B9F3E5AQ40311717-DFB7D6EC-66ED-4198-869A-8CD3156C95C5Q41909122-2BF7FE0C-1A97-429D-8BF4-559BB3060935Q42164450-81B4F07A-0E59-4891-9864-C9A2CC7487FFQ55513575-19279618-B198-44E0-8FEC-7C3847B44D46
P2860
Kaposi sarcoma-associated herpes virus targets the lymphotactin receptor with both a broad spectrum antagonist vCCL2 and a highly selective and potent agonist vCCL3
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Kaposi sarcoma-associated herp ...... ctive and potent agonist vCCL3
@ast
Kaposi sarcoma-associated herp ...... ctive and potent agonist vCCL3
@en
Kaposi sarcoma-associated herp ...... ctive and potent agonist vCCL3
@nl
type
label
Kaposi sarcoma-associated herp ...... ctive and potent agonist vCCL3
@ast
Kaposi sarcoma-associated herp ...... ctive and potent agonist vCCL3
@en
Kaposi sarcoma-associated herp ...... ctive and potent agonist vCCL3
@nl
prefLabel
Kaposi sarcoma-associated herp ...... ctive and potent agonist vCCL3
@ast
Kaposi sarcoma-associated herp ...... ctive and potent agonist vCCL3
@en
Kaposi sarcoma-associated herp ...... ctive and potent agonist vCCL3
@nl
P2860
P50
P356
P1476
Kaposi sarcoma-associated herp ...... ctive and potent agonist vCCL3
@en
P2093
Anders H Johnsen
Jesper Jurlander
P2860
P304
17794-17805
P356
10.1074/JBC.M702001200
P407
P577
2007-04-02T00:00:00Z